Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Pisansky

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Oncology|October 1, 1992
Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapyT M Pisansky, D J Schaid, C L Loprinzi, et al.
Cancer|January 15, 1997
A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinomaT M Pisansky, M J Kahn, G M Rasp, et al.
Mayo Clinic Proceedings|July 11, 2001
Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapyS J Buskirk, T M Pisansky, E J Atkinson, et al.
Techniques in Urology|May 8, 2000
Treatment of extraprostatic cancer in clinically organ-confined prostate cancer by permanent interstitial brachytherapy: is extraprostatic seed placement necessary?B J Davis, M G Haddock, T M Wilson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagusB D Minsky, D Neuberg, D P Kelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancerT M Pisansky, S S Cha, J D Earle, et al.
The Journal of Urology|June 24, 1999
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancerS K Quella, C L Loprinzi, J Sloan, et al.
Cancer|June 22, 1999
The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapyB J Davis, T M Pisansky, T M Wilson, et al.
The Journal of Urology|March 29, 2000
Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical marginB C Leibovich, D E Engen, D E Patterson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2000
Extranodal extension in lymph node-positive prostate cancerL Cheng, T M Pisansky, D M Ramnani, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|October 1, 1992
Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapyT M Pisansky, D J Schaid, C L Loprinzi, et al.
Cancer|January 15, 1997
A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinomaT M Pisansky, M J Kahn, G M Rasp, et al.
Mayo Clinic Proceedings|July 11, 2001
Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapyS J Buskirk, T M Pisansky, E J Atkinson, et al.
Techniques in Urology|May 8, 2000
Treatment of extraprostatic cancer in clinically organ-confined prostate cancer by permanent interstitial brachytherapy: is extraprostatic seed placement necessary?B J Davis, M G Haddock, T M Wilson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagusB D Minsky, D Neuberg, D P Kelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancerT M Pisansky, S S Cha, J D Earle, et al.
The Journal of Urology|June 24, 1999
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancerS K Quella, C L Loprinzi, J Sloan, et al.
Cancer|June 22, 1999
The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapyB J Davis, T M Pisansky, T M Wilson, et al.
The Journal of Urology|March 29, 2000
Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical marginB C Leibovich, D E Engen, D E Patterson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2000
Extranodal extension in lymph node-positive prostate cancerL Cheng, T M Pisansky, D M Ramnani, et al.
Pageof 4